The self assembled superanionic capsule [{Na+⊂(18-crown-6)(OH2)2}⊂{(p-sulfonatocalix[4]arene4−)2}]7− (X7−) forms a 1:1 crystalline complex with dinuclear [Rh2(μ-OH)2(H2O)8]4+ when the cation is treated with sodium p-sulfonatocalix[4]arene and 18-crown-6 at pH 2. The overall composition of the crystalline solid is [Rh2(μ-OH)2(H2O)8][X + 3 H+]·11.5H2O. Treatment of a complex mixture of polynuclear rhodium(III) aqua ions in perchloric acid with excess sodium p-sulfonatocalix[4]arene and 18-crown-6 at pH 2, results in selective retrieval of the tri- and tetranuclear rhodium(III) species in a single 1:1 co-crystallised phase, isolated as the hydrate salt with overall composition [Rh3(μ-OH)4(H2O)10][Rh4(μ-OH)6(H2O)12][2 X + 3 H+][Na(H2O)(ClO4)]2·27H2O. The tri- and tetranuclear Rh cations both have a cyclic structure with μ-hydroxide and terminal water ligands. Despite the differences in cation charge and size both complexes show the same arrangement of polynuclear cations and superanions although the trimer/tetramer complex shows additional coordination of a second Na centre by the calixarenes. At pH 0.35 the reaction leads to the selective retrieval of the tetranuclear cation in the complex [Rh4(μ-OH)6(H2O)12][X + {X − 2 H2O} + 8 H+]·33H2O, where a second type of dehydrated superanion is found, where the two sodium bound water molecules have been replaced by O-centres of calixarene sulfonate groups, illustrating the versatile nature of the superanion chemistry.
No takes yet. Share an insight, caveat, or question.
Drljaca et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: